Teva Pharmaceutical Industries Ltd.
P/S (Price-to-Sales)
Price
Sales Per Share
P/S (Price-to-Sales)
| Fiscal Year | P/S (Price-to-Sales) | Sales Per Share | Price |
|---|---|---|---|
| Dec 2016 | 1.86x | $19.50 | $36.25 |
| Dec 2017 | 0.86x | $22.03 | $18.95 |
| Dec 2018 | 0.86x | $17.90 | $15.42 |
| Dec 2019 | 0.63x | $15.48 | $9.80 |
| Dec 2020 | 0.63x | $15.21 | $9.65 |
| Dec 2021 | 0.56x | $14.34 | $8.01 |
| Jun 2022 | 0.66x | $13.90 | $9.12 |
| Sep 2022 | 0.67x | $13.53 | $9.12 |
| Dec 2022 | 0.68x | $13.45 | $9.12 |
| Mar 2023 | 0.78x | $13.39 | $10.44 |
| Jun 2023 | 0.78x | $13.41 | $10.44 |
| Sep 2023 | 0.78x | $13.46 | $10.44 |
| Dec 2023 | 0.74x | $14.16 | $10.44 |
| Dec 2024 | 1.51x | $14.63 | $22.04 |
| Dec 2025 | 2.59x | $12.08 | $31.34 |